Clinical trial
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414 is registered in ClinicalTrials.gov with Krystal Biotech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
- Lead sponsor
- Krystal Biotech, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 2, 2024
- Completion date
- December 31, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epidermolysis bullosa dystrophica, epidermolysis bullosa dystrophica dominans, epidermolysis bullosa dystrophica, recessive